baber/WOPTO huggingface dataset:
Patent AU-2019334666-A1 (AU)
Title: Medium for direct differentiation of pluripotent stem cell-derived mesenchymal stem cell, method for preparing mesenchymal stem cell by using same, and mesenchymal stem cell prepared thereby
Inventor: LEE DONG RYUL
IPC: C12N5/0775
Filed: 2019-09-06
Abstract: The present invention relates to a medium for direct differentiation of embryonic stem cell-derived mesenchymal stem cells, a method for preparing mesenchymal stem cells by using same, mesenchymal stem cells prepared thereby, and a cell therapy product comprising the same mesenchymal stem cells. In a medium composition and a method according to an embodiment, mesenchymal stem cells can be prepared at high yield within a short period of time. In addition, the method is simple in preparation procedure because of the absence of an embryoid body formation step and allows homogeneous cells to be prepared, thus advantageously providing a cell therapy product within a reduced period of time, compared to conventional methods.
Patent AU-2019370900-A1 (AU)
Title: Storage device for storing transport units
Inventor: ALTWEGG HEINZ
IPC: B65G1/137
Filed: 2019-10-28
Abstract: The invention relates to a storage device (1') for storing transport units (3'), comprising: a plurality of transport units (3'); a plurality of storage lines (12a'-12g'), which are designed to store transport units (3'); a feed line (11'), which is connected to the storage lines (12a'-12g') by means of respective first switches (111'); a measuring device (15'), which is arranged on the feed line (11') and is designed to determine an extent of a transport unit (3'); and a controller (16'), which is connected to the measuring device (15') and the first switches (111') and is designed to select, on the basis of the extent of the transport unit (3') determined by the measuring device (15'), a storage line (12a'-12g') for storing the transport unit (3').
Patent AU-2019381113-A1 (AU)
Title: Novel compound as protein kinase inhibitor, and pharmaceutical composition comprising thereof
Inventor: PARK JI-YEON
IPC: C07D401/14
Filed: 2019-11-14
Abstract: The present invention provides a novel compound having a protein kinase inhibitory activity, stereoisomers thereof or pharmaceutically acceptable salts thereof. The compound according to the present invention, stereoisomers thereof or pharmaceutically acceptable salts thereof are effective in preventing or treating protein kinase-related diseases such as cancers, autoimmune diseases, neurological diseases, metabolic diseases, infections or the like by showing a protein kinase inhibitory activity.
Patent AU-2019398214-A1 (AU)
Title: Fusion protein constructs for complement associated disease
Inventor: CURTIS MICHAEL STEVEN
IPC: A61K38/48
Filed: 2019-12-11
Abstract: Provided herein are fusion protein constructs that can bind a complement-associated antigen, comprising a targeting moiety and a complement modulator protein, or a fragment thereof or a variant thereof. The targeting moiety is an antibody or an antigen binding fragment thereof, in some examples. Further provided are methods of using the fusion protein constructs, for example, in treating complement mediation conditions.
Patent AU-2019403731-A1 (AU)
Title: Electrolyte compositions
Inventor: BORAH ROHAN
IPC: H01G11/60
Filed: 2019-12-20
Abstract: Disclosed are electrolyte compositions for electrochemical devices, where the electrolyte compositions comprise a microemulsion and where the microemulsion comprises an aqueous phase and a water-immiscible phase. Also disclosed are microemulsion electrolyte compositions for electrically rechargeable electrochemical energy storage devices, including ion batteries (such as lithium ion, sodium ion, magnesium ion, calcium ion, and aluminium ion batteries), redox flow batteries and supercapacitors.
Patent AU-2019416316-A1 (AU)
Title: Home appliance and method for voice recognition thereof
Inventor: LEE NOKHAENG
IPC: G10L21/0208
Filed: 2019-12-19
Abstract: A home appliance is disclosed. The home appliance includes a communication device configured to communicate with another home appliance, a microphone configured to receive a voice from a user, and a processor configured to perform signal processing on first voice data obtained from the microphone and perform voice recognition using the signal-processed first voice data, wherein the processor generates noise data using second voice data received from the other home appliance and performs the signal processing on the first voice data using the generated noise data.
Patent AU-2019432912-A1 (AU)
Title: Dynamically adapting assistant responses
Inventor: KRALJIC TANYA
IPC: G10L15/22
Filed: 2019-03-01
Abstract: Techniques are disclosed that enable dynamically adapting an automated assistant response using a dynamic familiarity measure. Various implementations process received user input to determine at least one intent, and generate a familiarity measure by processing intent specific parameters and intent agnostic parameters using a machine learning model. An automated assistant response is then determined that is based on the intent and that is based on the familiarity measure. The assistant response is responsive to the user input, and is adapted to the familiarity measure. For example, the assistant response can be more abbreviated and/or more resource efficient as the familiarity measure becomes more indicative of familiarity.
Patent WO-2020191447-A1 (WO)
Title: Rail mounting device and method for its use
Inventor: TURBET LIAM
IPC: E01B9/42
Filed: 2020-03-26
Abstract: A vehicle rail mounting device (10) is disclosed. comprising base formations (18, 20, 22), which are assembled to form one component, with elastomer (32) therebetween. The lower formation is bottom plate (18) which is adapted to be supported on a rail substrate, and the upper plates (20, 22) are adapted for the vehicle rail to be mounted thereon. The bottom plate (18) is a generally elongate and rectangular-shaped, in which there are two adjacent, generally rectangular-shaped central cavities (24, 26). The bottom plate (18) comprises a four-sided perimetrical wall (42) shaped like a frame, which has an interior-facing surface and the cavities (24, 26) are separated by an elongate barrier element in the form of an internal wall (44) which is arranged to be transverse to the major elongate axis of the bottom plate (18), so that the internal wall (44) spans the width of the central cavity.
Patent WO-2020232515-A1 (WO)
Inventor: MOLLOY PETER
IPC: A61P31/14
Filed: 2020-06-10
Abstract: This invention is directed to methods for prevention of infections by highly pathogenic (HP) viruses by applying to the nasal mucous membranes a topical preparation comprising the broad-spectrum antimicrobial agent povidone-iodine (PVP-I). Said viruses include SARS and MERS Coronaviruses, such as SARS-CoV-2 (which causes COVID-19), Filoviridae such as Ebola Virus (EBOV), Marburg Virus (MARV), Sudan Virus (SUDV), Tai Forest Virus (TAFV) and Bundibugyo Virus (BDBV), pandemic influenza viruses such as H5N1, H5N9, H7N3, H7N7, H9N2 and H1N1, and Arenaviridae that cause Lassa fever, Junin and Machupo, Bunyaviridae that cause Crimean-Congo haemorrhagic fever, Rift Valley Fever, Hantaan haemorrhagic fevers, and Flaviviridae that cause yellow fever, dengue, Omsk haemorrhagic fever, Kyasanur forest disease. The present invention further relates to a method of decreasing secondary infections from a primary HP viral infection, caused by bacteria or fungus such as  Mycoplasma pneumoniae, S. aureus, K. pneumoniae, S. pneumoniae, M. catarrhalis, P. aeruginosa, S. pyogenes, or Streptococcus agalactiae.
Patent WO-2020257845-A1 (WO)
Inventor: O'FLAHERTY BRENDAN
IPC: A61M13/00
Filed: 2020-06-23
Abstract: The present invention provides a particulate delivery device with an automatic activation mechanism that pierces or cuts a composition capsule when a cap is removed. The cap cannot be replaced once the device is activated for use. The device allows for gas flow through the device from a gas inlet to a gas outlet through a composition receptacle and dispersion chamber to deliver particulate to the airway of a subject.
Patent AU-2020200992-A1 (AU)
Title: Scaffolding mesh system
Inventor: YU ERIC
IPC: E04G5/14
Filed: 2020-02-12
Abstract: A system for screening a scaffold comprising rigid metal mesh panels (100) located on 
the exterior of the scaffolding and attached thereto using brackets (12) . The mesh 
panels have a mass of less than about 10Kg and comprise a rectangular frame (102), 
typically made from tubes having a rectangular or square cross section and a mesh 
panel (104) mounted in the frame forming a mesh panel screen.
4/14 
Fig 16 2-cO Fig17 
Fig 
Fig 18 Fig 19 Fig 20
Patent AU-2020202571-A1 (AU)
Title: A neural substrate for sugar preference
Inventor: ZUKER CHARLES
IPC: C07K14/43
Filed: 2020-04-16
Abstract: This invention concerns a composition and a method of modulating the craving and/or desire 
for natural sugar in a subject comprising: agonizing or stimulating or antagonizing or silencing a 
selective group of neurons in the cadual nucleus of the solitary tract (cNST) of the brain in the 
subject, whether directly or via the gut or gut-brain axis.
Patent AU-2020203019-A1 (AU)
Title: System and method for mitigating broadband interference
Inventor: HARTLESS MAC L
IPC: H04W24/00
Filed: 2020-05-07
Abstract: A method for operating a communication device so as to mitigate 
intermodulation interference to a signal, includes the steps of: 
(i) continuously monitoring a plurality of communication channels 
by the communication device 604; 
(ii) using a noise floor level estimate of the communication device 
to detect when the communication device is under an influence of high 
interference 606; 
(iii) determining an optimal level of attenuation to be applied by a 
variable attenuator of the communication device's receiver so as to mitigate the 
influence of intermodulation interference doe to an interference signal 608; and 
(iv) selectively adjusting an amount of attenuation being applied by 
the variable attenuator to achieve the optimal level of attenuation 610.
6/10 
MethodBei 
62 6006: 
Continuously monitoring a channel, and receiving noise and/or signals at a 
Communication Device ("CD") 604 
Detect when the CD is under the influence of IM interference 
based on a noise floor level of the CD 606 
Determine an optimal level of attenuation to be applied by a Variable Attenuator ("VA") prior 
to the front end hardware 608 
Selectively adjusting an amount of attenuation being applied by the VA 
based on the optimal level of attenuation 610 
End or perform othe6r2 
processing 
FIG. 6
Patent AU-2020206399-A1 (AU)
Title: Use of chlorogenic acid in preparing medicine or pharmaceutical composition for preventing or treating pain
Inventor: ZHANG JIE
IPC: A61K31/216
Filed: 2020-01-10
Abstract: A use of chlorogenic acid in the preparation of a medicine for preventing or treating pain, the pain comprises cancer pain, skeletal muscle pain and the like. A medicine for preventing or treating pain, the medicine being a pharmaceutical preparation prepared by using chlorogenic acid as an active ingredient and adding pharmaceutically acceptable auxiliary materials. Chlorogenic acid may effectively relieve cancer pain and bone joint pain, and may replace analgesic drugs such as opioids and non-steroidal anti-inflammatory drugs in treatment.
Patent AU-2020212661-A1 (AU)
Title: Method for Beam Failure Recovery, Method for Beam Failure Handling, Terminal, and Network-Side Device
Inventor: YANG YU
IPC: H04W72/08
Filed: 2020-01-02
Abstract: Provided are a beam failure recovery method, a processing method, a terminal and a network side device. The method comprises: acquiring N pieces of configuration information, wherein the N pieces of configuration information are respectively applicable to different transmitting and receiving points (TRPs), and the configuration information includes parameters for beam failure recovery; and where it is determined that a beam failure event occurs in at least one TRP, sending a beam failure recovery request according to the configuration information.
Patent AU-2020220242-A1 (AU)
Title: Compositions and methods for enhanced lymphocyte-mediated immunotherapy
Inventor: LUM JULIAN J
IPC: A61P35/00
Filed: 2020-02-12
Abstract: Lymphocytes having a suppressed autophagy gene useful in immunotherapy are disclosed. The lymphocytes can express an antigen targeting receptor such as a chimeric antigen receptor (CAR) or endogenous or engineered T-cell receptor to target cells expressing a tumor-specific antigen. Methods of making and using such lymphocytes are disclosed. Some such lymphocytes are useful in conducting CAR-T or TCR-T therapy.
Patent AU-2020221966-A1 (AU)
Title: Cryopreservation of stem cells
Inventor: LOMBARDO DE LA CAMARA ELEUTERIO
IPC: A01N1/02
Filed: 2020-02-11
Abstract: The invention relates to methods for the cryopreservation of a stem cell population, including mesenchymal stem cells (MSCs) such as adipose-derived stromal stem cells (ASCs). More particularly, the invention relates to the use of N-acetylcysteine (NAC) in cryopreservation methods, populations of cells obtained from said methods, compositions comprising said cells and uses thereof.
Patent AU-2020226190-A1 (AU)
Title: Methods for treating liver cancers using an orally administered dioxolane nucleotide in combination with an anti-PD1 or anti-PDL1 monoclonal antibody
Inventor: ALBERTELLA MARK
IPC: A61K39/395
Filed: 2020-02-17
Abstract: Use of a compound of the formula (I): or a pharmaceutically acceptable salt thereof, in the therapy of a liver cancer in a mammal, characterized by the concurrent or sequential treatment of the mammal with a monoclonal antibody which blocks the binding of PD-L1 and/or PD-L2 to PD-1.
Patent AU-2020245535-A1 (AU)
Title: Devices and methods for delivering pharmaceutical compositions
Inventor: MATHAI ASHANTHI
IPC: A61M5/00
Filed: 2020-03-25
Abstract: Described herein are devices for delivering pharmaceutical compositions to individuals in need thereof. Also described herein are methods of using the devices described herein to deliver pharmaceutical compositions to individuals in need thereof.
Patent AU-2020250181-A1 (AU)
Title: Zone heating for respiratory circuits
Inventor: BUSWELL MATTHEW LIAM
IPC: A61M16/00
Filed: 2020-10-06
Abstract: The present invention provides a medical tube comprising: a first and second segment each 
configured to transport a humidified gas, wherein the first and second segments comprise a 
first and second heater wire circuit, respectively; and an intermediate connector that connects 
the patient-end of the first segment and a chamber-end of the second segment to form a single 
conduit for the humidified gas, wherein at least a portion of the intermediate connector is 
covered by a portion of the first segment and/or a portion of the second segment such that the 
intermediate connector is internal to the medical tube, wherein electrical power passes through 
a connection circuit within the intermediate connector to provide power to one or both of the 
first and second heater wire circuits. A controller is adapted to selectively switch between 
providing power to the first heater wire circuit or both heater wire circuits.
WO 2014/077706 PCT/NZ2013/000208 
1/31 
C~Oj 
L----------------------------
Patent AU-2020276233-A1 (AU)
Title: New kaurane analogues,their preparation and therapeutically uses
Inventor: NOT GIVEN
IPC: A61P15/10
Filed: 2020-05-12
Abstract: Synthesis of novel kaurane analogues, their preparation, and their uses in cardiac protection against ischemia, hypertrophy and chemotherapy induced cardiomyopathy as well as cerebral ischemia. Wherein R
Patent AU-2020280905-A1 (AU)
Title: Cyclodextrin based injectable coformulations of SGLT2 inhibitors and incretin peptides
Inventor: LAINE ANNE-LAURE
IPC: A61P1/16
Filed: 2020-05-20
Abstract: Provided herein are coformulations comprising cyclodextrin that allow for concurrent, subcutaneous administration of sodium glucose co-transporter 2 inhibitors (SGLT2i), such as dapagliflozin, and incretin peptides, such as GLP-1/Glucagon dual agonist peptides.
Patent AU-2020333759-A1 (AU)
Title: Color coding for chemistries and instruments utilized in a chemical test
Inventor: TSCHAMPL MICHAEL JONATHAN
IPC: B01L3/00
Filed: 2020-08-19
Abstract: The invention provides a method for selecting a color for a chemistry or instrument based upon a parameter of a test, the method including: identifying a color corresponding to a parameter of a test for the parameter; selecting, if the color corresponding to the parameter has not previously been used for another parameter, the color for designating a chemistry or an instrument as corresponding to the parameter; selecting, if the color corresponding to the parameter has previously been used for another parameter, a different color other than the color for designating a chemistry or an instrument as corresponding to the parameter, wherein the selecting a color other than the color comprises identifying a color having a measure of change in visual perception of the different color against other previously selected colors a predetermined value from the other previously selected colors; and utilizing the selected colors for parameters across both chemistries (102, 104, 105) and instruments (101, 103) that are utilized in tests for the parameters.
Patent AU-2020337968-A1 (AU)
Title: Systems and methods for wearable devices that determine balance indices
Inventor: DOUGLAS JOHN
IPC: A61B5/00
Filed: 2020-08-28
Abstract: The present disclosure relates to systems and methods for balance index determination. For example, a wearable apparatus may have at least one gyroscope configured to measure angular velocity about a first axis; at least one inertial measurement device (IMU) configured to measure deviation along a second axis and a third axis; at least one memory storing instructions; and at least one processor configured to execute the instructions to: receive angular velocity measurements (1010) over a period of time from the at least one gyroscope; receive deviations from the second axis (1020) and from the third axis (1030) over the period of time from the at least one IMU; weight the deviations (1040) based on directions associated with the deviations; and generate a composite balance index (1050) based on the angular velocity measurements, the weighted deviations from the second axis, and the weighted deviations from the third axis.
Patent AU-2020378208-A1 (AU)
Title: System and method for disambiguation and error resolution in call transcripts
Inventor: GURBANI VIJAY K
IPC: G10L15/18
Filed: 2020-11-09
Abstract: A system and method for detecting and resolving mis-transcriptions in a transcript generated by an automatic speech recognition system when transcribing spoken words. The system and method receive a machine language generated transcript of a speech signal by at least one of a first machine learning system and a second machine learning system, and analyze the machine language generated transcript to find a region of low confidence indicative of a mis-transcription and predict an improvement to the region of low confidence indicative of the mis-transcription. The system and method select a replacement word for the mis-transcription based on the predicted improvement to the region of low confidence and replace the mis-transcription by the replacement word to generate a corrected transcript.
Patent AU-2020384121-A1 (AU)
Title: GLP-1 receptor agonist and use thereof
Inventor: YOON HONG CHUL
IPC: A61K31/496
Filed: 2020-11-13
Abstract: Disclosed are novel compounds of Chemical Formula 1, optical isomers of the compounds, and pharmaceutically acceptable salts of the compounds or the optical isomers. The compounds, isomers, and salts exhibit excellent activity as GLP-1 receptor agonists. In particular, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used as therapeutic agents for metabolic diseases. Moreover, they exhibit excellent pharmacological safety for cardiovascular systems.
Patent AU-2020384279-A1 (AU)
Title: 5-membered heteroarylaminosulfonamides for treating conditions mediated by deficient CFTR activity
Inventor: LIAO JUNKAI
IPC: C07D277/52
Filed: 2020-11-12
Abstract: The invention relates to heteroaryl compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.
Patent AU-2020389020-A1 (AU)
Title: Artificial nanopores and uses and methods relating thereto
Inventor: MAGLIA GIOVANNI
IPC: B82Y15/00
Filed: 2020-11-19
Abstract: The invention relates to the field of nanopores and the use thereof in analyzing biopolymers, including polypeptides and polynucleotides. Provided is an artificial nanopore comprising a multimeric assembly of subunits, each subunit comprising (i) the transmembrane (TM) sequence of a β-barrel or α-helical pore forming protein fused to the amino acid sequence of (ii) a subunit of a ring-forming protein capable of controlling the transport of a polypeptide or polynucleotide across the TM region of the assembly.
Patent AU-2020392424-A1 (AU)
Title: Methods of treating pulmonary arterial hypertension
Inventor: MARESTA ALESSANDRO
IPC: A61K31/4985
Filed: 2020-11-27
Abstract: The disclosure relates to methods of reducing the risk of disease progression in a patient with pulmonary arterial hypertension (PAH), comprising administering to a patient in need thereof, an initial triple combination therapy of an endothelin receptor antagonist (ERA), a phosphodiesterase type 5 (PDE-5) inhibitor, and a prostacyclin receptor agonist (IP receptor agonist).
Patent AU-2020408153-A1 (AU)
Title: Easy mounting cable grounding assemblies for telecommunications enclosures
Inventor: CAMS EDDY LUC
IPC: H02G3/08
Filed: 2020-12-14
Abstract: Electrical grounding assemblies for electrically grounding cables in cable closures. A grounding unit of the grounding assembly can serve as a common ground connection to multiple cables. The grounding unit includes mounting features that allow it to be easily mounted and unmounted from a slotted base plate positioned within the cable closure.
Patent AU-2020415850-A1 (AU)
Title: Automatic film cutting and bottle feeding machine
Inventor: XUE YONGXIANG
IPC: B67C3/24
Filed: 2020-06-03
Abstract: An automatic film cutting and bottle feeding machine, comprising a frame (1), and a bottle pushing mechanism (2), a film cutting mechanism (3), and a film suction mechanism (4) which are provided on the frame (1). One side of the frame (1) is provided with a transport mechanism (5); the exit of the transport mechanism (5) is provided with a bottle delivery mechanism (6); the film cutting mechanism (3) is used for cutting an outer packaging film of an entire group of bottles; the film suction mechanism (4) is used for suctioning away the off-cut packaging film; the bottle pushing mechanism (2) is used for pushing the bottles with the packaging film removed to the transport mechanism (5). According to the automatic film cutting and bottle feeding machine, the packaging film on bottles are cut by means of the film cutting mechanism (3), then the bottles with the packaging film removed are pushed to the transport mechanism (5) by means of the bottle pushing mechanism (2), and then the bottles are transported to the bottle delivery mechanism (6) by means of the transport mechanism (5), and finally delivered by the bottle delivery mechanism (6), thereby achieving a high degree of automation; moreover, the film suction mechanism (4) is also provided and can suction away the off-cut packaging film, thereby saving labor; thus, the production efficiency and economic benefits are improved.